Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » About Us » Our Staff » Andrew P. Han

Andrew P. Han

Editor
Phone Number
+1-212-651-5640
Email
[email protected]

Andrew Han covers breaking news for GenomeWeb. He tracks companies in the sequencing and diagnostic markets.

Articles Authored by Andrew P. Han

Sep 15, 2020

Japanese Startup BitBiome Builds Single-Cell Bacterial Sequencing Services Business

Premium

The Tokyo-based firm is looking to expand into the US market following a recent ¥700 million ($6.6 million) Series B financing round.

Sep 09, 2020

Adaptive Biotechnologies, Takara Bio T Cell Receptor Sequencing Methods Rank High in Benchmarking Study

Premium

An international team of researchers put nine immune cell sequencing methods head to head, including RNA-based and DNA-based ones, using the same T-cell sample.

Aug 31, 2020

New Methods Boost Scale of Single-Cell Gene Expression Dynamics Studies

Premium

Labs are finding cheaper, higher-throughput ways to determine the inflection points in gene expression within a particular cell.

Aug 26, 2020

US Court Orders Illumina to Produce Inventors for Deposition in BGI Patent Lawsuit

BGI will have a chance to depose up to nine inventors of patents assigned to Illumina as part of a lawsuit over IP related to sequencing-by-synthesis chemistry.

Aug 25, 2020

Loop Genomics Seeks Slice of Sanger Market With New Clonal Isolate Library Preparation Technology

Premium

The Bay Area firm has built on its enzymatic barcoding technology to deliver a high-throughput, synthetic long-read library preparation technique.

Aug 17, 2020

Bionano Genomics Expecting Clinical Validation Studies to Drive Platform Adoption

Premium

The firm is hoping that researcher-generated data will soon be published in peer-reviewed papers, while it weathers the COVID-19 pandemic.

Aug 11, 2020

NanoString Launches NGS Readout for Spatial Transcriptomics, Partners With Illumina on Informatics

Premium

The firm has partnered with Illumina to use the Dragen Bio-IT informatics platform to help customers analyze data from the new Cancer Transcriptome Atlas panel.

Aug 07, 2020

Illumina Sees Expanding Sequencing Market in COVID-19 Response, Despite Short-Term Woes

Premium

The sequencing firm said infectious disease research, diagnostics, screening, and surveillance could all increase demand for its NGS products.

Aug 05, 2020

Fulgent Genetics Touts Returns on COVID-19 Testing Investment

Premium

Company officials credited investments in information technology, as well as R&D for RT-PCR-based tests, with driving up the firm's billable testing numbers.

Jul 30, 2020

Double-Barcoded Single-Cell Library Prep Solves Index-Hopping Issues, Lowers Sequencing Costs

Premium

Two companies offering droplet-based single-cell RNA sequencing sample prep, 10x Genomics and 1Cellbio, have launched dual-indexed library preparation products.

The Scan

Plans Out

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

CovidNudge Numbers

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

Science Papers Propose Group to Discuss Genome-Editing Tools, Markers of Diabetes Drug Response, More

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

Not Counting These

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.